With ambitious goals and compelling technology, Graphite Bio is frequently in the news. Keep up on the latest press releases and select stories below.
FierceBiotech: Graphite Bio debuts with $45M to cure sickle cell disease using gene edits 
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Graphite Bio, its subsidiaries or affiliates. No use of any Graphite Bio trademark, trade name, or trade dress in this site may be made without the prior written authorization of Graphite Bio, except to identify the product or services of the company.
©Copyright 2020 Graphite Bio, Inc. All rights reserved.